Medical Services

Risk Profiles

Risk profiles are used to help classify prostate cancer in terms of treatment options.

Low Risk

  • PSA of 10 or lower

  • Gleason Score between 2-6

  • Clinical stage of T2a or less (confined to a small area on the digital rectal exam or not


    palpable at all) 

Treatment options: Depending upon the age and health of the patient, any of the listed Treatment Options would be appropriate except Hormone Therapy alone. 

(or Medium) Risk

  • PSA of greater than 10, but less than or equal to 20 or lower

  • Gleason Score of 7

  • Clinical stage of T2b

Treatment options: Further testing might be necessary to better define the extent of disease. These tests may include a bone scan, CT scan and/or MRI. Depending upon the age and health of the patient, any of the listed Treatment Options would be appropriate. Usually Watchful Waiting would be limited to older patients or those with other medical conditions.

High Risk

  • PSA exceeding 20

  • Gleason Score between 8-10

  • Clinical stage of T3 or higher

Treatment options: Like intermediate risk prostate cancer, further testing may be recommended to better define the extent of disease. Depending upon the age and health of the patient, any of the listed Treatment Options would be appropriate. Usually Watchful Waiting would be limited to older patients or those with other medical conditions.